197 related articles for article (PubMed ID: 12077355)
1. Hyperproliferation, induction of c-Myc and 14-3-3sigma, but no cell fragility in keratin-10-null mice.
Reichelt J; Magin TM
J Cell Sci; 2002 Jul; 115(Pt 13):2639-50. PubMed ID: 12077355
[TBL] [Abstract][Full Text] [Related]
2. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis.
Müller FB; Huber M; Kinaciyan T; Hausser I; Schaffrath C; Krieg T; Hohl D; Korge BP; Arin MJ
Hum Mol Genet; 2006 Apr; 15(7):1133-41. PubMed ID: 16505000
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the suprabasal keratin network by mutation M150T in the helix initiation motif of keratin 10 does not affect cornified cell envelope formation in human epidermis.
Akiyama M; Takizawa Y; Sawamura D; Matsuo I; Shimizu H
Exp Dermatol; 2003 Oct; 12(5):638-45. PubMed ID: 14705805
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest.
Paramio JM; Segrelles C; Ruiz S; Jorcano JL
Mol Cell Biol; 2001 Nov; 21(21):7449-59. PubMed ID: 11585925
[TBL] [Abstract][Full Text] [Related]
5. Loss of keratin 10 is accompanied by increased sebocyte proliferation and differentiation.
Reichelt J; Breiden B; Sandhoff K; Magin TM
Eur J Cell Biol; 2004 Dec; 83(11-12):747-59. PubMed ID: 15679119
[TBL] [Abstract][Full Text] [Related]
6. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice.
Reichelt J; Furstenberger G; Magin TM
J Invest Dermatol; 2004 Nov; 123(5):973-81. PubMed ID: 15482487
[TBL] [Abstract][Full Text] [Related]
7. Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice.
Reichelt J; Büssow H; Grund C; Magin TM
Mol Biol Cell; 2001 Jun; 12(6):1557-68. PubMed ID: 11408568
[TBL] [Abstract][Full Text] [Related]
8. The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis.
Santos M; Paramio JM; Bravo A; Ramirez A; Jorcano JL
J Biol Chem; 2002 May; 277(21):19122-30. PubMed ID: 11889133
[TBL] [Abstract][Full Text] [Related]
9. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE
Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742
[TBL] [Abstract][Full Text] [Related]
10. Abnormal keratin 1 and 10 cytoskeleton in cultured keratinocytes from epidermolytic hyperkeratosis caused by keratin 10 mutations.
Huber M; Scaletta C; Benathan M; Frenk E; Greenhalgh DA; Rothnagel JA; Roop DR; Hohl D
J Invest Dermatol; 1994 May; 102(5):691-4. PubMed ID: 7513736
[TBL] [Abstract][Full Text] [Related]
11. Keratins K2 and K10 are essential for the epidermal integrity of plantar skin.
Fischer H; Langbein L; Reichelt J; Buchberger M; Tschachler E; Eckhart L
J Dermatol Sci; 2016 Jan; 81(1):10-6. PubMed ID: 26603179
[TBL] [Abstract][Full Text] [Related]
12. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation.
Stoler A; Kopan R; Duvic M; Fuchs E
J Cell Biol; 1988 Aug; 107(2):427-46. PubMed ID: 2458356
[TBL] [Abstract][Full Text] [Related]
13. Loss of keratin K2 expression causes aberrant aggregation of K10, hyperkeratosis, and inflammation.
Fischer H; Langbein L; Reichelt J; Praetzel-Wunder S; Buchberger M; Ghannadan M; Tschachler E; Eckhart L
J Invest Dermatol; 2014 Oct; 134(10):2579-2588. PubMed ID: 24751727
[TBL] [Abstract][Full Text] [Related]
14. Severe abnormalities in the oral mucosa induced by suprabasal expression of epidermal keratin K10 in transgenic mice.
Santos M; Bravo A; López C; Paramio JM; Jorcano JL
J Biol Chem; 2002 Sep; 277(38):35371-7. PubMed ID: 12119299
[TBL] [Abstract][Full Text] [Related]
15. The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE.
Porter RM; Reichelt J; Lunny DP; Magin TM; Lane EB
J Invest Dermatol; 1998 Jun; 110(6):951-7. PubMed ID: 9620304
[TBL] [Abstract][Full Text] [Related]
16. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma).
Ishida-Yamamoto A; McGrath JA; Judge MR; Leigh IM; Lane EB; Eady RA
J Invest Dermatol; 1992 Jul; 99(1):19-26. PubMed ID: 1376754
[TBL] [Abstract][Full Text] [Related]
17. Out of balance: consequences of a partial keratin 10 knockout.
Reichelt J; Bauer C; Porter R; Lane E; Magin V
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2175-86. PubMed ID: 9378767
[TBL] [Abstract][Full Text] [Related]
18. Delays in malignant tumor development in transgenic mice by forced epidermal keratin 10 expression in mouse skin carcinomas.
Santos M; Ballestín C; Garcia-Martín R; Jorcano JL
Mol Carcinog; 1997 Sep; 20(1):3-9. PubMed ID: 9328431
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid.
Tang XH; Vivero M; Gudas LJ
Exp Cell Res; 2008 Jan; 314(1):38-51. PubMed ID: 17727842
[TBL] [Abstract][Full Text] [Related]
20. A novel substitution in keratin 10 in epidermolytic hyperkeratosis.
Arin MJ; Longley MA; Anton-Lamprecht I; Kurze G; Huber M; Hohl D; Rothnagel JA; Roop DR
J Invest Dermatol; 1999 Apr; 112(4):506-8. PubMed ID: 10201536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
